Fractionation of Palliative Radiation Therapy in Metastatic Breast Cancer-Selection and Survival

被引：0
|
作者：
Qian, Y. [1 ]
Aggarwal, S. [2 ]
Dudley, S. A. [3 ]
Durkee, B. Y. [4 ]
Kumar, K. A. [2 ]
Chaudhuri, A. A. [5 ]
Pollom, E. [1 ]
von Eyben, R. [6 ]
Chang, D. T. [2 ]
Horst, K. C. [1 ]
机构：
[1] Stanford Canc Inst, Dept Radiat Oncol, Stanford, CA USA
[2] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[3] Stanford Dept Radiat Oncol, Stanford, CA USA
[4] Stanford Canc Inst, Stanford, CA USA
[5] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[6] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3259
引用
收藏
页码：E513 / E513
页数：1
相关论文
共 50 条
  • [41] The Influence of Breast Cancer Subtype on Survival after Palliative Radiation for Osseous Metastases
    Abdelhakiem, M. K.
    Johnstone, C.
    Bergom, C.
    Currey, A. D.
    Robbins, J. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E436 - E436
  • [42] Irinotecan as a Palliative Therapy for Metastatic Breast Cancer Patients after Previous Chemotherapy
    Lan, Hai
    Li, Yan
    Lin, Cong-Yao
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10745 - 10748
  • [43] Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer
    Rosvig, Lena H.
    Langkjer, Sven T.
    Knoop, Ann
    Jensen, Anders B.
    ACTA ONCOLOGICA, 2018, 57 (01) : 156 - 159
  • [44] EQ-VAS for Therapy Evaluation of palliative Chemotherapies for metastatic Breast Cancer
    Hassdenteufel, K.
    Brusniak, K.
    Feisst, M.
    Sebesteny, L.
    Engler, T.
    Hartkopf, A. D.
    Graf, J.
    Schneeweiss, A.
    Wallwiener, M.
    Deutsch, T. M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E98 - E98
  • [45] The Hidden Benefits of Palliative Radiation Therapy When Radiation of Metastatic Disease Is Not "Just Palliative"
    Huynh, Mai Anh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (05): : 1257 - 1259
  • [46] Survival analysis of palliative radiotherapy in patients with HER-2+metastatic breast cancer
    Li, Xueting
    Zhong, Xiaorong
    Xu, Hongyu
    Wang, Jun
    Liu, Xianguo
    Wang, Yang
    He, Liang
    Ma, Jiayu
    Li, Guanghua
    Liu, Lei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [47] Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014
    Yu, James B.
    Pollack, Craig E.
    Herrin, Jeph
    Zhu, Weiwei
    Soulos, Pamela R.
    Xu, Xiao
    Gross, Cary P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (06): : 493 - 499
  • [48] Palliative radiation therapy in bladder cancer: a matter of dose, techniques and patients' selection
    Jereczek-Fossa, Barbara A.
    Marvaso, Giulia
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (05) : 786 - 789
  • [49] The effect of timing and dose fractionation on stereotactic radiation therapy for lung cancer metastatic to the brain
    Kelley, J.
    Cameron, B.
    Benedict, S.
    Broaddus, W.
    Chung, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S265 - S266
  • [50] Radiation therapy in combination with immune checkpoint inhibitors in metastatic lung cancer: Effect of fractionation
    Rosso, Christopher
    Reed, Melissa
    Walde, Natalie
    Voutsadakis, Ioannis A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (03) : 300 - 309
12345